Dr. Horst Hemmerle Eli Lilly & Company Director Lead Generation Technologies: Responsible for: Compound Collection Enrichment Strategy Screening Strategies.

Slides:



Advertisements
Similar presentations
1 Real World Chemistry Virtual discovery for the real world Joe Mernagh 19 May 2005.
Advertisements

Dr Claes Wilhelmsson Executive Director Research & Development Innovation and the life sciences.
The Drug Discovery Process
Combating diseases with small molecule compounds
1 Pharmaceutical Challenges for the Semantic Web.
Proteomics and “Orphan” Receptors Yvonne (Bonnie) Eyler Technology Center 1600 Art Unit 1646 (703)
National Association of Chronic Disease Directors January 2013 Dr. Jewlya Lynn Jason Vahling.
Systems Biology Existing and future genome sequencing projects and the follow-on structural and functional analysis of complete genomes will produce an.
Systems Biology approaches to understanding glutathione metabolism 29 September 2010 Dr Najl Valeyev Edinburgh University of Kent Centre for Molecular.
S TRUCTURAL B IOINFORMATICS. A subset of Bioinformatics concerned with the of biological structures - proteins, DNA, RNA, ligands etc. It is the first.
Cell Biology Lecture 3. Function of Plasma Membrane Mechanical Support Cell Signaling Selective permeability Active transport Bulk Transport Metabolic.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
Chemical Genomics – Biol503 Lecture 2 Chemical Genomics and cancer/cardiovascular diseases.
Knowledge Commons: The Case of the Biopharmaceutical Industry Arti K. Rai Duke Law School.
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
Knowledgebase Creation & Systems Biology: A new prospect in discovery informatics S.Shriram, Siri Technologies (Cytogenomics), Bangalore S.Shriram, Siri.
Topological Summaries: Using Graphs for Chemical Searching and Mining Graphs are a flexible & unifying model Scalable similarity searches through novel.
NIH Roadmap and Chemoinformatics Jeffery Loo NLM Associate Fellow Welch Library Journal Club 2004/12/7.
Sage Bionetworks Mission Sage Bionetworks is a non-profit organization with a vision to create a “commons” where integrative bionetworks are evolved by.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
GTL Facilities Computing Infrastructure for 21 st Century Systems Biology Ed Uberbacher ORNL & Mike Colvin LLNL.
Application of e-infrastructure to real research.
Understanding Knowledge There is More to Knowledge than Might be Known.
PHC 222 Medicinal Chemistry-1- Part(I) Dr. Huda Al Salem Lecture (1)
Drug Discovery Process Massimiliano Beltramo, PhD.
Function first: a powerful approach to post-genomic drug discovery Stephen F. Betz, Susan M. Baxter and Jacquelyn S. Fetrow GeneFormatics Presented by.
Page 1 SCAI Dr. Marc Zimmermann Department of Bioinformatics Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) Grid-enabled drug discovery.
James Anderson, M.D., Ph.D. Director Division of Program Coordination, Planning, and Strategic Initiatives October 27, 2011 The NIH Common Fund.
ASCAC-BERAC Joint Panel on Accelerating Progress Toward GTL Goals Some concerns that were expressed by ASCAC members.
1 Cheminformatics David Shiuan Department of Life Science and Institute of Biotechnology National Dong Hwa University.
Samudrala group - overall research areas CASP6 prediction for T Å C α RMSD for all 70 residues CASP6 prediction for T Å C α RMSD for all.
Combinatorial Chemistry. Synthesis of many structures (diversity) combinatorial technology, combinatorial library molecular diversity What is Combinatorial.
Strategies for developing India as a contract research hub Swaminathan Subramaniam Chief Operating Officer Aurigene Discovery Technologies.
Automated Hypothesis Generation Based on Mining Scientific Literature Scott Spangler, Angela D. Wilkins, Benjamin J. Bachman, Meena Nagarajan, Tajhal Dayaram,
Biological Signal Detection for Protein Function Prediction Investigators: Yang Dai Prime Grant Support: NSF Problem Statement and Motivation Technical.
Bioinformatics MEDC601 Lecture by Brad Windle Ph# Office: Massey Cancer Center, Goodwin Labs Room 319 Web site for lecture:
Avian Flu Data Challenge Hsin-Yen Chen ASGC 29 Aug APAN24.
Limitation of animal models in drug discovery and development Candice Tahimic, Ph.D. Hence, there is a need to use human cells to test the efficacy of.
COMPUTERS IN BIOLOGY Elizabeth Muros INTRO TO PERSONAL COMPUTING.
Histone Methyltransferases: Global Industry Report for Research Tools, Diagnostics and Drug Discovery
ECCR Overview/MLSCN. NIH Roadmap Series of initiatives designed to pursue major opportunities in biomedical research and gaps in current knowledge that.
PharmaMiner: Geometric Mining of Pharmacophores 1.
Joe Pekny, Professor Chemical Engineering Director, e-Enterprise Center Discovery Park Marietta Harrison, Professor Medicinal Chemistry & Molecular Pharmacology.
PubChem: An Open Repository for Chemical Structure and Biological Activity Information Steve Bryant The NIH Biowulf Cluster: 10 Years of Scientific Supercomputing.
Discovery of Therapeutics to Improve Quality of Life Ram Samudrala University of Washington.
Basic Translational Clinical New Pathways to Discovery Harmonization Target ID & Valid. Phases I-III Research Teams of Future Translational Cores Clinical.
Małopolska Centre of Biotechnology (MCB) X-Ray Crystallography Laboratory Looking into the deep – structural investigations of biological macromolecules.
Milanesi Luciano Catania, Italy 13/03/2007 Bioinformatics challenges in European projects in Grid. Milanesi Luciano National Research Council Institute.
A truly integrated drug discovery company 26 th April 2016 CONFIDENTIAL.
신기술 접목에 의한 신약개발의 발전전망과 전략 LGCI 생명과학 기술원. Confidential LGCI Life Science R&D 새 시대 – Post Genomic Era Genome count ‘The genomes of various species including.
Molecular Modeling in Drug Discovery: an Overview
TIDEA Target (and Lead) Independent Drug Enhancement Algorithm.
Development of Concepts for R&D Management R&D in an Individual Enterprise.
Designing Drugs Virtually P14D461P - Arni B. Hj. Morshidi P14D389P - Anisah Bt Ismail P14D397P - Syarifah Rohaya Bt Wan Idris P14D394P - Dayang Adelina.
Page 1 Transporter Screening -Profacgen. Page 2 Transporters are a group of specialized membrane proteins that power the translocation of numerous substances,
Page 1 Molecular Modeling Service in Profacgen. Page 2 The three-dimensional structure of a protein provides essential information about its biological.
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Can Drug Discovery Research be Done At An Undergraduate Institution?
ATOM Accelerating Therapeutics for Opportunities in Medicine
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
The percentage of NASs approved by CDER
Small molecules that perturb the function of their targets on fast time scales can be powerful probes of dynamic cellular processes, such as intracellular.
Branko Stefanovic Biomedical Sciences
PREDICT.
Drug Design and Drug Discovery
Consortium: National networks in 16 European countries.
Consortium: National networks in 16 European countries.
Forward and reverse genetic approaches in Drosophila.
History of antibiotic discovery and concomitant development of antibiotic resistance. History of antibiotic discovery and concomitant development of antibiotic.
Presentation transcript:

Dr. Horst Hemmerle Eli Lilly & Company Director Lead Generation Technologies: Responsible for: Compound Collection Enrichment Strategy Screening Strategies – Target families DCRT Technologies /Automation Chemoinformatics/Chemogenomics

Disease mechanism FAS VEGF Cellular mechanism Molecular mechanism Prostate Cancer Angiogenesis Annotated chemical diversity compounds Targets Apoptosis Solving Complex Issues Informatcis platforms allow integration and creation of knowledge Analysis – Predictions - Simulations

Library Deliverables Dynamic Library compoundsdata Iterative Screen Panels KinasesGPCRs NHRsIon Channels ProteasesLipases Transporters Ideal Drug Properties Structural Novelty Kinases GPCRs NHRs MTS of selected cassettes for Drug Discovery efforts Selected sets for Target of Interest evaluation Validation Tools (Hits,Fragments) Ligands to Explore Polypharm Hits/Leads/Back-up Scaffolds Active Compounds and Information

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.